FRANZE', Maria Stella
 Distribuzione geografica
Continente #
EU - Europa 454
NA - Nord America 344
AS - Asia 125
Totale 923
Nazione #
US - Stati Uniti d'America 344
IE - Irlanda 160
IT - Italia 134
SE - Svezia 85
SG - Singapore 52
CN - Cina 34
IN - India 26
DE - Germania 22
PL - Polonia 20
FI - Finlandia 11
ID - Indonesia 7
AT - Austria 5
BE - Belgio 4
VN - Vietnam 4
CZ - Repubblica Ceca 3
NL - Olanda 3
RU - Federazione Russa 3
BD - Bangladesh 1
HU - Ungheria 1
KG - Kirghizistan 1
LV - Lettonia 1
NO - Norvegia 1
PT - Portogallo 1
Totale 923
Città #
Dublin 160
Chandler 106
Nyköping 64
Messina 53
Singapore 42
Ashburn 27
Warsaw 20
Hyderabad 19
Princeton 15
Avola 13
Medford 13
Munich 13
New York 12
Ann Arbor 11
Des Moines 10
Dearborn 9
Helsinki 8
Catania 7
Jakarta 7
Los Angeles 7
Jacksonville 6
Pune 6
Pachino 5
Vienna 5
Beijing 4
Boardman 4
Bremen 4
Brussels 4
Cambridge 4
Dong Ket 4
Jinan 4
Nanjing 4
Nuremberg 4
Tianjin 4
Amsterdam 3
Haikou 3
San Mateo 3
Seattle 3
Brno 2
Guangzhou 2
Lappeenranta 2
Rome 2
Scandicci 2
Washington 2
Zhengzhou 2
Belpasso 1
Bishkek 1
Catanzaro 1
Houston 1
Huilong 1
Jiaxing 1
Kunming 1
Lisbon 1
Milan 1
Ningbo 1
Niscemi 1
Norwalk 1
Olomouc 1
Oslo 1
Pittsburgh 1
Redwood City 1
Riga 1
Rosolini 1
San Benedetto del Tronto 1
San Giorgio di Piano 1
Shenyang 1
Sopron 1
Sortino 1
Woodbridge 1
Yicheng 1
Yuncheng 1
Totale 730
Nome #
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 109
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 72
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 68
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 61
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 58
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 55
The changing scenario of hepatocellular carcinoma in Italy: an update 55
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 49
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 48
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 47
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 44
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 41
Pattern of macrovascular invasion in hepatocellular carcinoma 39
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 37
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 36
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 36
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 32
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 25
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 20
null 19
Natural Course of COVID-19 and Independent Predictors of Mortality 17
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 11
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 10
Totale 989
Categoria #
all - tutte 5.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.047


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 0 0 1 10 3 0 2 5 7 1
2020/202176 3 1 14 4 11 2 6 2 4 24 1 4
2021/2022126 5 10 2 4 7 6 17 1 4 16 19 35
2022/2023412 23 48 16 28 29 38 6 23 185 3 12 1
2023/2024144 7 16 3 16 9 30 0 9 1 30 4 19
2024/2025174 5 27 19 48 75 0 0 0 0 0 0 0
Totale 989